LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
08/04/2026
Back to search
Official data from USPTO
V VALNEVA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
08/04/2026
Trademark type
Combined
Nice classes
1, 5, 42
Filing date
07/16/2014
Registration date
07/21/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/12/2025
Last transaction
08/04/2026
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
Saint Herblain, FR
Examiner
HOLTZ, ALLISON
Current location
Historical data usage
Mark description
The mark consists of a stylized "V" consisting of three diagonal lines, first light blue, then blue, then light blue, and the word "VALNEVA" in stylized form in dark blue.
Holders and representatives
Holders
VALNEVA
VALNEVA
Representatives
Christina M. Licursi Wolf, Greenfield & Sacks, P.C.
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical productsfungicidesherbicidesinsecticides and parasiticides for use in industryscience as well as in agriculture; molecules from bio technologiesproteins in raw material for scientific and medical research; cells for scientificlaboratory or medical research; cell lines for scientific and medical research; nucleic acids for laboratory use; proteins for industrial use; recombinant proteins for industrial use; biomedical compoundspeptides substrates; peptide antigens used in analyzing and detecting certain toxins for researchclinicalmedical laboratory use; Biochemical preparations derived from blood serum for use in scientific and medical research; Bio chemicalsantibodies and fragments thereof for in vitro scientific or research useChemicals for use in biotechnological product development; cultures of microorganisms other than for medical and veterinary use; virusescellsbiologicalbacteriological or viral preparationsother than for nucleic acids for scientificlaboratorymedical research
Class 5
Pharmaceutical products for human and veterinary use for the treatment of auto immune diseasesinflammationcancerinfectious diseasesdiseases of the central nervous systemcardiovascular diseasesneurodegenerative and chronic diseases; medicalbiologicalbiotechnologicalproteinvirologicalimmunologicalbacteriologicalchemicalenzymatic and pharmaceutical preparations for medical and veterinary use; medicalbiologicalbiotechnologicalproteinvirologicalimmunologicalbacteriologicalchemicalenzymatic and pharmaceutical productspreparation of encapsulated cells which release antibodies for medical and veterinary use; diagnostic productsdiagnostic preparations for use in humanveterinary medicine and pharmaceutical use; cellmicroorganism or virus cultures for medical and veterinary use; adjuvants for medical or veterinary use; antibioticsvaccinesvirusesviral vectorsnucleic acidsproteinsrecombinant proteinspeptidespeptide antigensblood serumantibodies and fragments thereofcells for medicalpharmaceutical and veterinary use; viral substancesimmunological substancesbacterial substancesenzyme substances used for human and veterinary medicine; diagnostic kits consisting primarily of antibodies and fragments thereof for use in disease testing; diagnostic kits primarily of antibodies and antibody fragments for use in disease testing
Class 42
Scientific research services for medical purposes in the fields of auto immune diseasesinflammationcancerinfectious diseasesdiseasesdiseases of the central nervous systemcardiovascular diseasesneurodegenerative and chronic diseases; scientific research for medicalpharmaceutical and veterinary purposes in the fields of auto immune diseasesinflammationcancerinfectious diseasesdiseases of the central nervous systemscardiovascular diseasesneurodegenerative and chronic diseases; scientific and industrial researchin particular in the fields of biologycellular and molecular biologybiotechnologybacteriologyimmunologygeneticsgene studymedicinepharmacologyvirologychemistry; scientific research relating to vaccinesantibiotics and immunological products for human and veterinary use; research and development of new products for others; testing and evaluations of the goods of others to assure compliance with industry standards in the scientificmedical and veterinary fields; research and development of new products for human and veterinary use; scientific researchpreparation of scientific experts opinion reports in the scientificmedical and veterinary fields; development and design of laboratory instruments for scientific and industrial researchin particular to obtain and prepare cellscell linesvirusesproteinsanimal and human materials; development of vaccinesantibiotics and immunological products for human and veterinary use; scientific and technological servicesdiagnostic and prognostic analyses in the fields of cellscell linesanimal and human materialsmicroorganismsmolecules for scientific purposes; scientific researchpreparation of scientific expert opinions reports
Publications
History of USPTO decisions and trademark events.
47 publications found
RHRD
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
07/09/2026
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
08/12/2025
71AG
REGISTERED-SEC.71 ACCEPTED
08/12/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/29/2025
ES71
TEAS SECTION 71 RECEIVED
05/12/2025
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
07/21/2024
RNWL
INTERNATIONAL REGISTRATION RENEWED
06/07/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/15/2022
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
08/24/2021
C75A
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
08/24/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/24/2021
ES75
TEAS SECTION 71 & 15 RECEIVED
04/13/2021
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/21/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/26/2019
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
12/13/2018
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
12/22/2016
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/08/2016
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/09/2015
FIMP
FINAL DISPOSITION PROCESSED
12/09/2015
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/21/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
07/21/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/05/2015
PUBO
PUBLISHED FOR OPPOSITION
05/05/2015
GPNX
NOTIFICATION PROCESSED BY IB
05/02/2015
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/15/2015
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/15/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/15/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/31/2015
ALIE
ASSIGNED TO LIE
03/30/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/12/2015
XAEC
EXAMINER'S AMENDMENT ENTERED
03/12/2015
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/12/2015
GNEA
EXAMINERS AMENDMENT E-MAILED
03/12/2015
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/12/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/23/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/23/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/23/2015
RFNT
REFUSAL PROCESSED BY IB
01/04/2015
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/15/2014
RFRR
REFUSAL PROCESSED BY MPU
12/15/2014
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/12/2014
MAFR
APPLICATION FILING RECEIPT MAILED
12/12/2014
CNRT
NON-FINAL ACTION WRITTEN
12/11/2014
DOCK
ASSIGNED TO EXAMINER
12/08/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/08/2014
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/04/2014
Continuous trademark protection
Get notified about every new filing that threatens V VALNEVA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.